The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.
Barack Obama – 2008
I’d also like to congratulate all the candidates for the 5th Annual Prix Galien Awards Competition, which honors
those in the pharmaceutical industry who have developed the technical, scientific and clinical research skills
necessary to develop innovative medicines and devices.
Your work is invaluable.
Margaret A. Hamburg, M.D.Commissioner of Food and Drugs Food and Drug Administration - 2011
I am particularly grateful to receive this award on behalf of all the people who work in our Foundation.
Bill Clinton – 2010
The Prix Galien USA recognizes the important research necessary to develop innovative medicines and
devices that have a lifesaving impact on individuals and families across the globe.
Kathleen Sebelius, Secretary of Health and Human Services - 2011
Prix Galien recognizes men and women from the pharmaceutical and biomedical industries
whose contributions of science have improved and saved countless lives.
I commend the Galien Foundation for its leadership in this vital field.
Michael Bloomberg, Mayor of New York City
The Prix Galien is the right event, on the right issue at the right time.
I thank the Galien Foundation for bringing us together and for recognizing that a healthier world
is a safer world and a more just world.
Ban Ki-moon, United Nations Secretary-General – 2010
When Olympic rhymes with Galenic: there is a gold medal that can be won for an extraordinary achievement:
this is the Galien Award, the Oscar of pharmaceutical research.
Walter Sutter, State Advisor, Director of the Public Economy – 2004. Switzerland
It is a pleasure to congratulate all those who promote the Prix Galien and pharmaceutical research:
they play a vital role in the fight against disease throughout the world.
John Major, Prime Minister – 1996. United Kingdom
We recognize the importance of the Prix Galien in promoting drug research,
and we salute the excellent work of the Jury.
Philippe Douste-Blazy, Minister of Health – 2004.
Minister of Foreign Affairs - 2006.
Vice-Secretary General of the United Nations - 2008. France
The Prix Galien is a prestigious award, a magnificent occasion to pay recognition to our researchers
and to encourage our industry.
Jean Cretien, Prime Minister – 1994. Canada
The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.
Barack Obama – 2008
Tuesday, October, 22, 2013 - New York City
Alexandria Center™ for Life Science
Preliminary Program
-7:45 - 8:30: Introduction:
Chair: Dr. P.Roy Vagelos, Chairman of Regeneron Pharmaceuticals and retired Chairman and Chief Executive Officer at Merck & Co., Inc.
Keynote Speaker: Bert Vogelstein, Johns Hopkins School of Medicine.
Joel Marcus, Chairman A.R.E.
Neil de Crescenzo, General Manager, Oracle Health Sciences
-8:30 - 9:35: New Mechanisms for Industry-Academia Interactions: Successes and Obstacles
Chair: Dr. Michael Rosenblatt, Executive Vice-President and Chief Medical Officer, Merck & Co., Inc.
Panelists:
Dr. Christopher Austin,Director, National Center for Advancing Translational Sciences - National Institutes of Health
Pr. Michael S.Brown, Regental Professor, University of Texas, Southwestern Medical Center
Dr. John Thomas Potts Jr., Neuroendocrine Clinical Center, Harvard Medical School
- 9:35 - 10:40: Improving efficiency in drug development:
Chair: Dr. Mikael Dolsten, President Worldwide Research and Development, Pfizer,Inc.
Panelists:
Dr. Jeff Leiden, Chairman, President and CEO, Vertex
Dr. Jan Lundberg, Executive Vice President, Science and Technology and President, Lilly Research Labs, Lilly & Co.
Dr. Elliott Sigal, Executive Vice President, Chief Scientific Officer and President, R&D, Bristol-Myers Squibb
- 10:40 - 11:00: Coffee Break
- 11:00 - 12:05: Personalized medicine, Effect on drug R&D
Chair: Pr. Joseph Goldstein, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center at Dallas
Panelists:
Dr. David Altshuler, Massachusetts General Hospital and Broad Institute
Dr. Richard Lifton, Yale University School of Medicine
Dr. Jonathan Sheldon, Global Senior Director of Translational Medicine, Oracle Health Sciences.
Dr. Bert Vogelstein, Johns Hopkins School of Medicine
Dr. Huda Zoghbi, Baylor College of Medicine
Sponsored by Oracle Lifesciences.
-12:05 - 12:45: Lunch Break
-12:45 - 1:50: Affordable Care Act. US Healthcare in Transition: The Stakes for Industry
Chair: Dr. P. Roy Vagelos
Ken Frazier, Chairman, CEO and President, Merck & Co., Inc.
Alex Gorsky, Chairman and CEO, Johnson&Johnson
John Lechleiter, Chairman and CEO, Eli Lilly & Company
-1:50 - 2:55: Neurodegenerative Disease Drug Progress
Chair: Pr. Marc Tessier-Lavigne, President, The Rockefeller University, New York, Professor Laboratory of Brain Development and Repair
Sponsored by Alexandria Real Estate
-2:55 - 4:00: Oncology: Newer Therapies:
Chair: Dr. Paul A. Marks, Laboratory Head of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, President, Emeritus, MSKCC
Panelists:
Clifford Hudis, Chief, Breast Cancer Medicine Services, Memorial Sloan-Kettering Cancer Center
Mark Kris, Chief, Thoracic Oncology Services, Memorial Sloan-Kettering Cancer Center
Howard Scher, Chief, Genitourinary Oncology Services, Memorial Sloan-Kettering Cancer Center
